Dorato Michael A, Buckley Lorrene A
Lilly Research Laboratories, Greenfield, Indiana, USA.
Curr Protoc Toxicol. 2007 Feb;Chapter 19:Unit19.1. doi: 10.1002/0471141755.tx1901s31.
The primary objective of toxicology studies in the drug discovery process is to evaluate the safety of potential drug candidates. This is accomplished using relevant animal models and validated procedures. The ultimate goal is to translate the animal responses into an understanding of the risk for human subjects. To this end the toxicologist must be aware of the international guidelines for safety evaluation as well as traditional and nontraditional toxicology models. As described in this unit, the typical toxicology profile consists of safety pharmacology, genetic toxicology, acute and subchronic toxicology, absorption, distribution, metabolism, and excretion (ADME) studies, reproductive and developmental toxicity, and an evaluation of carcinogenic potential.
药物研发过程中毒理学研究的主要目标是评估潜在候选药物的安全性。这是通过使用相关动物模型和经过验证的程序来实现的。最终目标是将动物反应转化为对人类受试者风险的理解。为此,毒理学家必须了解国际安全评估指南以及传统和非传统毒理学模型。如本单元所述,典型的毒理学概况包括安全药理学、遗传毒理学、急性和亚慢性毒理学、吸收、分布、代谢和排泄(ADME)研究、生殖和发育毒性以及致癌潜力评估。